Participating Faculty: Incorporating Emerging Innovation in Hemophilia A and B: Tailoring Prophylaxis and Management Strategies in the Managed Care Environment

Publishing Staff

Senior Vice President of Operations and Clinical Affairs

Jeff D. Prescott, PharmD, RPh

Senior Clinical Projects Manager

Ida Delmendo

Clinical Projects Manager

Cindy Spielvogel

Project Manager

Jessica Toye

Proofreaders

Griselda DemasseyMaggie Shaw

Associate Editor

Jeanne Linke

Assistant Editor

Sarah Anwar

Clinical Editor

Michael R. Page, PharmD, RPh

Designer

Julianne Costello

Associate Publisher

Justin T. Gallagher

Director of Sales

Sara Belanger

National Account Managers

Gabrielle ConsolaMichael Costella

Corporate

Chairman and CEO

Mike Hennessy, Sr

Vice Chairman

Jack Lepping

President

Mike Hennessy, Jr

Chief Operating Officer/CFO

Neil Glasser, CPA/CFE

President, Managed Markets, Pharmacy, and Rare Disease

Brian Haug

Executive Vice President and General Manager

John Maglione

Chief Creative Officer

Jeff Brown

Human Resources Director

Shari Lundenberg

President, Pharmacy Times Continuing Education

David Heckard

Faculty

Suchitra S. Acharya, MD

Director, Hemophilia Treatment Center

Long Island Jewish Medical Center

Northwell Health

Program Head, Bleeding Disorders and Thrombosis Program

Cohen Children’s Medical Center

New Hyde Park, New York

Professor of Pediatrics

Hofstra Northwell School of Medicine

Hempstead, New York

Sheh-Li Chen, PharmD, BCOP

Clinical Pharmacy Specialist in Benign Hematology

University of North Carolina Medical Center

Assistant Professor of Clinical Education

Division of Practice Advancement and Clinical Education

UNC Eshelman School of Pharmacy

Chapel Hill, North Carolina

Editorial Support

Priya Karkhanis

Scientific Consultant

Hillsborough, New Jersey

Faculty Disclosures

Suchitra S. Acharya, MD,

has the following relevant financial relationships with commercial interests to disclose:

Consultant:

Novo Nordisk, Bayer

Grant/research support:

Bayer Pharmaceuticals for hemophilia joint disease research— contracted research grant

Sheh-Li Chen, PharmD, BCOP, has no relevant financial relationships with commercial interests to disclose.

Editorial Support

Priya Karkhanis has no relevant financial relationships with commer-cial interests to disclose.

Participating Faculty

The American Journal of Managed Care

Publishing Staff—Jeff D. Prescott, PharmD, RPh; Ida Delmendo; and Cindy Spielvogel have no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education

Planning Staff—David Heckard; Maryjo Dixon, RPh; Neelam Davis, PharmD; Donna Fausak; Nathalie Harden; and Tara DeLorenzo have no relevant financial relationships with commercial interests to disclose.

Disclosure Policy

According to the disclosure policy of The American Journal of Managed Care and Pharmacy Times Continuing Education, all persons who are in a position to control content are required to disclose any relevant financial relationships with commercial interests. If a conflict is identified, it is the responsibility of Pharmacy Times Continuing Education to initiate a mechanism to resolve the conflict(s). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

Disclosure of Unapproved/Off-Label Use

The contents of this activity may include information regarding the use of products that may be inconsistent with or outside the approved labeling for these products in the United States. Participants should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.

The information provided in this CE activity is for continuing medical and pharmacy education purposes only and is not meant to substitute for the independent medical or pharmacy judgment of a physician or pharmacist relative to diagnostic, treatment, or management options for a specific patient’s medical condition.

The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of The American Journal of Managed Care, Pharmacy Times Continuing Education, or any of the companies that provided commercial support for this CE activity.

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.

Download PDF: Participating Faculty: Incorporating Emerging Innovation in Hemophilia A and B: Tailoring Prophylaxis and Management Strategies in the Managed Care Environment